ORAL Αvβ6/αvβ1 INTEGRIN INHIBITION IN PRIMARY SCLEROSING CHOLANGITIS: 12-WEEK INTERIM SAFETY AND EFFICACY ANALYSIS OF INTEGRIS-PSC, A PHASE 2a TRIAL OF BEXOTEGRASTGideon M. Hirschfield,Kris V. Kowdley,Michael Trauner,Palak J. Trivedi,Eric A. Lefebvre,Johanna Schaub,Martin Decaris,Annie Clark,Theresa Thuener,Hardean E. Achneck,Chris N. Barnes,Richard Pencek,Aldo J. Montano-Loza,Christopher L. Bowlus,Christoph Schramm,Cynthia LevyHEPATOLOGY（2024）引用 0|浏览13AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
